Analyst Ranking
Top 7%
#314 out of 5001 analysts
Average Return
+15.52%
Win Rate
62%72 out of 117
Risk vs Reward
Poor
Good

David Amsellem's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Indivior PLCINDV
+229.76%$7.46$24.60
2024-10-11 -
2025-09-02
Strong Buy
Amneal Pharmaceuticals IncAMRX
+222.28%$2.02$6.51
2023-05-08 -
2024-05-07
Strong Buy
Horizon Therapeutics Public Ltd CoHZNP
+189.77%$31.56$91.45
2020-04-14 -
2021-04-14
Strong Buy
Indivior PLCINDV
+173.33%$9.00$24.60
2024-10-25 -
2025-09-02
Strong Buy
Indivior PLCINDV
+148.74%$9.89$24.60
2025-03-06 -
2025-09-02
Strong Buy

David Amsellem Analyst Color

Get additional color on David Amsellem's coverage of popular stocks

David Amsellem's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Supernus Pharmaceuticals IncSUPN
11Hold$40.00-10.19%Maintains
5 days ago
Amgen IncAMGN
5Strong Buy$342.00+19.20%Maintains
9 days ago
Biogen IncBIIB
2Hold$118.00-15.49%Maintains
20 days ago
Abbvie IncABBV
1Strong Buy$231.00+9.00%Assumes
22 days ago
Amphastar Pharmaceuticals IncAMPH
8Hold$25.00-18.86%Maintains
a month ago
Corcept Therapeutics IncCORT
8Strong Buy$121.00+69.52%Maintains
a month ago
Neurocrine Biosciences IncNBIX
8Strong Buy$175.00+23.31%Maintains
a month ago
Sage Therapeutics IncSAGE
2Hold$8.50-2.07%Downgrades
3 months ago
Organon & CoOGN
6Strong Buy$18.00+91.08%Maintains
4 months ago
Collegium Pharmaceutical IncCOLL
7Hold$37.00-5.52%Reiterates
4 months ago
Jazz Pharmaceuticals PLCJAZZ
9Strong Buy$147.00+13.37%Reiterates
4 months ago
Bristol Myers Squibb CoBMY
1Strong Buy$65.00+37.10%Initiates Coverage On
4 months ago
Optinose IncOPTN
3Hold$9.00-6.25%Downgrades
5 months ago
Xeris Biopharma Holdings IncXERS
5Hold$4.00-49.49%Reiterates
6 months ago
Indivior PLCINDV
5Strong Buy$13.00-47.15%Maintains
6 months ago
Viatris IncVTRS
7Hold$10.00-5.30%Reiterates
6 months ago
Teva Pharmaceutical Industries LtdTEVA
7Strong Buy$30.00+60.00%Maintains
8 months ago
Intra Cellular Therapies IncITCI
1Hold$132.00+0.10%Downgrades
8 months ago
Avadel Pharmaceuticals PLCAVDL
4Strong Buy$13.00-13.22%Maintains
8 months ago
Amneal Pharmaceuticals IncAMRX
4Strong Buy$11.00+14.82%Maintains
10 months ago
Alkermes PLCALKS
7Strong Buy$37.00+25.85%Reiterates
10 months ago
Ani Pharmaceuticals IncANIP
1Strong Buy$68.00-27.74%Initiates Coverage On
a year ago
Revance Therapeutics IncRVNC
7Strong Buy$6.00N/AMaintains
a year ago
Bausch Health Companies IncBHC
4Strong Sell$3.00N/ADowngrades
a year ago
Pacira Biosciences IncPCRX
7Strong Buy$42.00N/AMaintains
a year ago
Aquestive Therapeutics IncAQST
1Strong Buy$10.00N/AInitiates Coverage On
a year ago
Ironwood Pharmaceuticals IncIRWD
3Strong Buy$21.00N/AMaintains
2 years ago
Axsome Therapeutics IncAXSM
3Strong Buy$113.00N/AMaintains
2 years ago
Cerevel Therapeutics Holdings IncCERE
2Hold$45.00N/ADowngrades
2 years ago
Tvardi Therapeutics IncTVRD
3Hold$12.00N/ADowngrades
2 years ago
Harmony Biosciences Holdings IncHRMY
3Strong Buy$42.00N/AMaintains
2 years ago
Eagle Pharmaceuticals IncEGRX
2Strong Sell$17.00N/ADowngrades
2 years ago
Karuna Therapeutics IncKRTX
1Strong Buy$285.00N/AInitiates Coverage On
3 years ago
Horizon Therapeutics Public Ltd CoHZNP
3Strong Buy$110.00N/AMaintains
3 years ago
Antares Pharma IncATRS
1Hold$5.60N/ADowngrades
3 years ago
Endo International PLCENDPQ
3Hold$3.00N/AMaintains
4 years ago
Biodelivery Sciences International IncBDSI
1Hold$5.60N/ADowngrades
4 years ago
Adamas Pharmaceuticals IncADMS
1Hold$8.00N/ADowngrades
4 years ago
Evofem Biosciences IncEVFM
1Strong Buy$165.00N/AInitiates Coverage On
5 years ago
Impax Laboratories IncIPXL
1HoldN/AN/AUpgrades
8 years ago
Societal Cdmo IncSCTL
1Strong Buy$12.00N/AInitiates Coverage On
9 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.